The Newcastle Muscle Centre is part of the Institute of Human Genetics, a 5* research organisation within Newcastle University. It is a centre of excellence for diagnosis, management and research into inherited neuromuscular diseases. The Muscle Centre is one of three centres in England for the diagnosis and management of inherited muscle diseases which are supported by the British Muscular Dystrophy Campaign. The Muscle Centre runs clinics in Newcastle and at various locations across the north of England.
IHG's Mission Statement:
Make the name of Newcastle synonymous with world class genetics research
IHG at Newcastle University's website
Contact: Volker Straub
Institute of Genetic Medicine
International Centre for Life
Newcastle upon Tyne
T:+44 191 241 8 655
Newcastle University and BIO-NMD
The Institute of Genetic Medicine at Newcastle University will be involved in three work packages for the project. WP1 - Patients' material organisation, circulation and managing of novel patients' fluids collection; WP8 - Social and ethical aspects; and WP9 - Exploitation and dissemination.
Newcastle University has its own biobank containing human material for dystrophinopathies and collagen 6 disorders as well as playing a key role in EuroBioBank. This enables them to effectively lead WP1.
As the coordinators of the TREAT-NMD network of excellence, Newcastle University will be able to draw on existing networks and dissemination tools to enable the team to lead WPs 8 and 9.
Kate Bushby is Professor of Neuromuscular Genetics. She has overseen the expansion of the Newcastle Muscle Centre since 1999 to its position today as a leading international neuromuscular centre. Together with Volker Straub, Katie is joint coordinator of the TREAT-NMD network.
Kate is also a member of the Scientific Advisory Committee of the AFM. In the UK she is Deputy Director of the MRC Centre for Neuromuscular Diseases at UCL and Newcastle and Clinical Director of the NCG diagnostic and advisory service for rare neuromuscular disorders (limb-girdle muscular dystrophies).
Emma Heslop joined the TREAT-NMD network in December 2006 as TREAT-NMD assistant project manager. Within TREAT-NMD she is responsible for leading the work relating to shared activities and tools; enhancing international relations and collaborations; coordinating the TREAT-NMD Advisory Committee for Therapeutics and representing the coordination office on the Project Ethics Council.
Her background is in Health and Human Sciences and Biological Anthropology. For six years she worked as a Project Coordinator in the Durham University Sleep Lab studying mother-infant sleep. During this time she completed her Biological Anthropology MSc (Research).
Hanns Lochmüller is Professor of Experimental Myology. He joined the Newcastle Muscle Centre in 2007 from Munich. Together with Volker Straub, Hanns was responsible for setting up the German muscular dystrophy network, MD-NET, of which he was Coordinator (jointly with Volker Straub) until 2008. He is the scientific coordinator of EuroBioBank, a European network of biobanks for rare disorders. Before coming to Newcastle University, Hanns held the post of Consultant and subsequently Professor of Neurology and Molecular Neurogenetics at Ludwig-Maximilians-University in Munich. He has a long-standing interest in the molecular genetics of the inherited myopathies and neuromuscular junction disorders, and his research focuses on the further study of animal models of these disorders as a means to understanding their pathophysiology, as well as to develop the means to monitor disease progression and therapeutic interventions.
Volker Straub is Professor of Neuromuscular Genetics. He is joint co-ordinator of TREAT-NMD, executive board member of the World Muscle Society and executive board member of the Institute of Genetic Medicine at Newcastle University.
Together with Hanns Lochmüller, Volker was responsible for setting up the German muscular dystrophy network, MD-NET, of which he was joint coordinator until 2008. Within the neuromuscular research group at Newcastle, Volker has a long-standing interest in the pathogenesis of muscular dystrophies, with research using zebrafish and mouse models. His current research also involves the application of contrast enhanced MRI.
Cathy Turner joined the BIO-NMD project in April 2010 as the communication and dissemination officer. She will be responsible for maintaining the BIO-NMD website and ensuring that information regarding the project is kept up to date and disseminated effectively to partners, patients and other interested parties.
Cathy has a background in journal publishing with Elsevier Science and Emerald Insight and has been working as a science teacher for the past 5 years. She has a degree in biochemistry, a post-graduate teaching certificate and a Masters in Business Administration.